Published in Perspect Sex Reprod Health on February 26, 2003
Do depression and low self-esteem follow abortion among adolescents? Evidence from a national study. Perspect Sex Reprod Health (2010) 0.95
Public Health Impact of Legal Termination of Pregnancy in the US: 40 Years Later. Scientifica (Cairo) (2012) 0.77
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ (2011) 29.14
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ (2010) 28.70
Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med (2008) 13.87
Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (2008) 11.08
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ (2013) 9.01
SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med (2013) 8.21
Guidance for developers of health research reporting guidelines. PLoS Med (2010) 7.43
CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol (2010) 7.04
CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med (2008) 5.85
Blinding in randomised trials: hiding who got what. Lancet (2002) 5.47
Bias and causal associations in observational research. Lancet (2002) 5.36
Refining clinical diagnosis with likelihood ratios. Lancet (2005) 4.84
Allocation concealment in randomised trials: defending against deciphering. Lancet (2002) 4.71
The comparative safety of legal induced abortion and childbirth in the United States. Obstet Gynecol (2012) 4.50
Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Syst Rev (2012) 4.36
Generation of allocation sequences in randomised trials: chance, not choice. Lancet (2002) 4.35
Sample size calculations in randomised trials: mandatory and mystical. Lancet (2005) 4.30
CONSORT for reporting randomised trials in journal and conference abstracts. Lancet (2008) 4.20
Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'. Trials (2008) 4.17
An overview of clinical research: the lay of the land. Lancet (2002) 4.04
Uses and abuses of screening tests. Lancet (2002) 3.96
Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. Ann Intern Med (2008) 3.63
Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med (2012) 3.63
CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg (2011) 3.57
Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev (2012) 3.37
Guidelines for reporting health research: the EQUATOR network's survey of guideline authors. PLoS Med (2008) 3.22
Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research. Stat Med (2002) 3.16
Electronic fetal monitoring as a public health screening program: the arithmetic of failure. Obstet Gynecol (2010) 2.89
Second-trimester abortion for fetal anomalies or fetal death: labor induction compared with dilation and evacuation. Obstet Gynecol (2011) 2.83
The Good Clinical Practice guideline: a bronze standard for clinical research. Lancet (2005) 2.81
Descriptive studies: what they can and cannot do. Lancet (2002) 2.73
Sample size slippages in randomised trials: exclusions and the lost and wayward. Lancet (2002) 2.62
Describing reporting guidelines for health research: a systematic review. J Clin Epidemiol (2011) 2.61
Epidemiologic research using administrative databases: garbage in, garbage out. Obstet Gynecol (2010) 2.50
Case-control studies: research in reverse. Lancet (2002) 2.38
Multiplicity in randomised trials II: subgroup and interim analyses. Lancet (2005) 2.34
Multiplicity in randomised trials I: endpoints and treatments. Lancet (2005) 2.32
Helping editors, peer reviewers and authors improve the clarity, completeness and transparency of reporting health research. BMC Med (2008) 2.25
Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network. BMC Med (2010) 2.24
Cohort studies: marching towards outcomes. Lancet (2002) 2.20
Emergency contraception: politics trumps science at the U.S. Food and Drug Administration. Obstet Gynecol (2004) 2.14
Immediate post-partum insertion of intrauterine devices. Cochrane Database Syst Rev (2010) 1.78
Opportunities and challenges for improving the quality of reporting clinical research: CONSORT and beyond. CMAJ (2004) 1.77
Compared to what? Finding controls for case-control studies. Lancet (2005) 1.74
Improving the reporting of randomised trials: the CONSORT Statement and beyond. Stat Med (2012) 1.73
Education for contraceptive use by women after childbirth. Cochrane Database Syst Rev (2012) 1.68
Hormonal contraceptives for contraception in overweight or obese women. Cochrane Database Syst Rev (2010) 1.61
Social desirability bias in family planning studies: a neglected problem. Contraception (2009) 1.50
The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials 2001. Explore (NY) (2005) 1.49
Oral contraceptives for functional ovarian cysts. Cochrane Database Syst Rev (2014) 1.45
Unequal group sizes in randomised trials: guarding against guessing. Lancet (2002) 1.45
The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Clin Oral Investig (2003) 1.44
Strategies to improve adherence and acceptability of hormonal methods of contraception. Cochrane Database Syst Rev (2011) 1.44
Sex hormone-binding globulin: not a surrogate marker for venous thromboembolism in women using oral contraceptives. Contraception (2008) 1.43
Weighing the evidence--metaquality and immunologic problems in in vitro fertilization cycles? Fertil Steril (2005) 1.38
False alarms and pseudo-epidemics: the limitations of observational epidemiology. Obstet Gynecol (2012) 1.38
Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease. Hum Mol Genet (2011) 1.35
Making sense of odds and odds ratios. Obstet Gynecol (2008) 1.32
The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Hum Mol Genet (2004) 1.29
CONSORT 2010 Statement: updated guidelines for reporting parallel group randomized trials. Open Med (2010) 1.29
Reducing publication bias through trial registration. Obstet Gynecol (2007) 1.27
Interventions for pain with intrauterine device insertion. Cochrane Database Syst Rev (2009) 1.24
Allocation concealment in clinical trials. JAMA (2002) 1.19
Surrogate end points in clinical research: hazardous to your health. Obstet Gynecol (2005) 1.18
Noncontraceptive health benefits of intrauterine devices: a systematic review. Obstet Gynecol Surv (2002) 1.17
Intrauterine devices for adolescents: a systematic review. Contraception (2009) 1.17
Advance provision of emergency contraception for pregnancy prevention: a meta-analysis. Obstet Gynecol (2007) 1.13
Routine follow-up visits after first-trimester induced abortion. Obstet Gynecol (2004) 1.12
Nonspecific side effects of oral contraceptives: nocebo or noise? Contraception (2010) 1.07
Peer review of statistics in medical research. Reporting power calculations is important. BMJ (2002) 1.06
Pitfalls of research linking the intrauterine device to pelvic inflammatory disease. Obstet Gynecol (2013) 1.05
Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev (2009) 1.04
Immediate postabortal insertion of intrauterine devices. Cochrane Database Syst Rev (2010) 1.03
Reducing publication bias of prospective clinical trials through trial registration. Contraception (2007) 1.03
Effective medical education: insights from the Cochrane Library. Obstet Gynecol Surv (2008) 1.03
Strategies to improve adherence and acceptability of hormonal methods of contraception. Cochrane Database Syst Rev (2013) 1.02
Education for contraceptive use by women after childbirth. Cochrane Database Syst Rev (2010) 0.99
Theory-based strategies for improving contraceptive use: a systematic review. Contraception (2009) 0.97
Interpreting the number needed to treat. JAMA (2002) 0.97
Combination contraceptives: effects on weight. Cochrane Database Syst Rev (2014) 0.97
A Nurr1 point mutant, implicated in Parkinson's disease, uncouples ERK1/2-dependent regulation of tyrosine hydroxylase transcription. Neurobiol Dis (2007) 0.94
Clinical practice. A request for abortion. N Engl J Med (2011) 0.93
Combination contraceptives: effects on weight. Cochrane Database Syst Rev (2011) 0.93
The EQUATOR Network and reporting guidelines: Helping to achieve high standards in reporting health research studies. Maturitas (2009) 0.92
Theory-based interventions for contraception. Cochrane Database Syst Rev (2013) 0.92
VAMP1 mutation causes dominant hereditary spastic ataxia in Newfoundland families. Am J Hum Genet (2012) 0.91
Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database Syst Rev (2013) 0.91
Resources for authors of reports of randomized trials: harnessing the wisdom of authors, editors, and readers. Trials (2011) 0.90
Nonhormonal drugs for contraception in men: a systematic review. Obstet Gynecol Surv (2005) 0.90
20 µg versus >20 µg estrogen combined oral contraceptives for contraception. Cochrane Database Syst Rev (2013) 0.89
Combination contraceptives: effects on weight. Cochrane Database Syst Rev (2008) 0.89
Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane Database Syst Rev (2014) 0.88